Seqomics

Seqomics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.7M

Overview

Seqomics is a private, revenue-generating Hungarian biotech firm providing NGS and analytical services while conducting its own research. The company leverages platforms like Illumina MiSeq and Ion Torrent PGM to offer sequencing, bioinformatics, and specialized lab services in food safety and animal health. Its business model combines contract service revenue with grant-funded R&D, positioning it at the intersection of applied genomics services and academic research. Key activities include metagenomics, ancient DNA analysis, and collaborative research on human genetics, antimicrobial resistance, and cancer.

Genetics & Genomics

Technology Platform

Integrated next-generation sequencing platform utilizing Illumina MiSeq and Ion Torrent PGM systems, supported by Agilent TapeStation for QC, q-PCR, and in-house bioinformatics capabilities. Specializes in metagenomics and ancient DNA analysis.

Funding History

2
Total raised:$1.7M
Seed$1.2M
Grant$500K

Opportunities

Growing demand for NGS services in food safety, animal health, and academic research in Central Europe provides a clear expansion path.
The company's strong publication record in areas like antimicrobial resistance and metagenomics positions it to secure lucrative research grants and high-value collaborative projects.

Risk Factors

Intense competition in the NGS services market could pressure margins.
Reliance on grant funding for R&D introduces revenue volatility.
Geographic location outside a major biotech hub may limit access to talent and large international clients.

Competitive Landscape

Seqomics competes with large international genomics service providers (e.g., Eurofins, Novogene) and local diagnostic labs. Its differentiation lies in its specialized expertise in areas like ancient DNA and metagenomics, its integrated bioinformatics, and its hybrid service-research model, which appeals to academic and institutional clients in its region.